Join Us March 13th @ 1 pm ET BEFORE Nvidia’s “Q-Day”

In 2016 Louis Navellier made a big prediction regarding Nvidia’s GPUs... It went up more than 7,000% at its peak. Don’t miss Louis NEXT Nvidia call. (Plus 6 stocks you need to own before March 20th.)

Thu, March 13 at 10:00AM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

The Millionaire’s Shortlist: 3 Get-Rich Stocks to Buy Now

By Yiannis Zourmpanos, InvestorPlace Contributor
In the current financial environment, those who want to reduce risks and maximize profits must be able to recognize good possibilities among market swings.

Is Tilray Stock Your Ticket to the Coming U.S. Cannabis Gold Rush?

By David Moadel, InvestorPlace Contributor
Tilray stock is an obvious buy in 2024 as Tilray Brands considers making strategic asset acquisitions in the U.S. and abroad.

The 3 Most Undervalued Pharma Stocks to Buy in June 2024

By Larry Ramer, InvestorPlace Contributor
These undervalued pharma stocks to buy are worth a look because even when the economy is struggling, consumers need key medicines.

Short Squeeze Specialists: 3 Stocks With the Expertise to Defy Bearish Expectations

By Josh Enomoto, InvestorPlace Contributor
For those seeking blistering returns in a relatively short amount of time, short-squeeze stocks may be the go-to place. Here, contrarians leverage the power of…

Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?

By Dana Blankenhorn, InvestorPlace Contributor
Novavax will be ready for the new Covid-19 JN.1 variants in September, but NVAX stock is also undergoing a short squeeze.

Trade of the Day: Cutera (CUTR) Stock Presents a Short Squeeze Opportunity

By Josh Enomoto, InvestorPlace Contributor
Although Cutera’s implosion over the past year is ugly, the bears may have pushed their leverage too far. This bodes well for CUTR stock.

Why Is Aethlon Medical (AEMD) Stock Up 82% Today?

By William White, InvestorPlace Writer
Aethlon Medical stock is up on Thursday with heavy trading of AEMD shares despite a lack of news from the medical therapeutic company.

Why Is Virax Biolabs (VRAX) Stock Up 115% Today?

By William White, InvestorPlace Writer
Virax Biolabs stock is up on Thursday alongside heavy pre-market trading of VRAX shares despite a lack of news from the company.

Exit Strategy: 3 Overvalued Stocks to Sell Before They Deflate

By Faisal Humayun, InvestorPlace Contributor
These are the overvalued stocks to sell. They represent quality companies that are worth buying after a 20% to 30% downside.

Sleep Easy: 3 Safe Stocks That Won’t Have You Stressin’

By Yiannis Zourmpanos, InvestorPlace Contributor
Explore three safe stocks to buy with sharp fundamentals in pharmaceuticals, household products, and restaurants.

7 F-Rated Stocks to Avoid at All Costs in June

By Louis Navellier and the InvestorPlace Research Staff
For many people, the most important thing about investing is knowing which stocks to buy, and when to buy them. If you’re a buy-and-hold investor,…

7 Stocks That Could Safely 10X by 2030

By Omor Ibne Ehsan
Unlock the potential for exponential growth with these seven 10x stocks that could skyrocket by 2030 if the stars align.

Growth Stock Goliaths: 7 Picks That Will Tower Over the Competition

By Joel Baglole, InvestorPlace Contributor
Investors who want to put some sizzle in their portfolios should consider investing in these growth names that offer big returns.

Hedge Fund Favorites: 7 Stocks to Buy When You’re Feeling Jittery

By Josh Enomoto, InvestorPlace Contributor
With the market entering a historically challenging season (due to the adage buy in May and go away), jittery investors may want to turn to…

Mid-Year Momentum Plays: 7 Stocks to Buy for the Second Half

By Josh Enomoto, InvestorPlace Contributor
There’s certainly some level of comfort in bidding up the same names as everybody else. But the most satisfying returns stem from momentum stocks that…

The 3 Most Undervalued Cannabis Stocks to Buy in June 2024

By Ian Cooper, InvestorPlace Contributor
Undervalued cannabis stocks may be some of the most controversial trades on the market. But they’ve also proven themselves profitable.

Why Is Novavax (NVAX) Stock Up 20% Today?

By Josh Enomoto, InvestorPlace Contributor
Novavax continues to march higher in its recovery efforts, with its latest vaccine announcement lifting NVAX stock.

3 Growth Stocks That Could 10X by December 2024

By Omor Ibne Ehsan
These three growth stocks are firing on all cylinders, making them prime candidates to deliver explosive gains by the end of 2024.

The 3 Best Biotech Stocks to Buy in June 2024

By Shane Neagle, InvestorPlace Contributor
Explore the best biotech stocks to buy in June 2024, with insights on Protagonist, BridgeBio and Intellia.
Load More Articles